Amplification of nucleic acid fragments using nicking agents
CA 2492007 A1 · Owner: Van Ness, Lori K. · Inventors: Van Ness, Lori K.; Van Ness, Jeffrey; Galas, David J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds kits and methods for detecting a , genetic variation in a target nucleic acid detecting the presence, or the , absence of a particular nucleic acid in a biological sample preparing single-, stranded nucleic acid probes and detecting pre-mRNA differential splicing in a target cDNA molecule or a cDNA population. It utilizes a nicking agent in the amplification of a single-stranded nucleic acid fragment that either contains a genetic variation of the target nucleic acid has a unique sequence , correlating to the particular nucleic acid is complementary to a nucleic acid , of interest or comprises an exon-exon junction. Detection and/or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 15, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 15, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 15, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.